Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4

Nature Communications

Volumn 6, Issue , 2015, Pages

  Kaplan, Zane S ^a   Zarpellon, Alessandro ^b   Alwis, Imala ^a,c   Yuan, Yuping ^a   McFadyen, James ^a   Ghasemzadeh, Mehran ^a,d   Schoenwaelder, Simone M ^a,c   Ruggeri, Zaverio M ^b   Jackson, Shaun P ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PROTEINASE ACTIVATED RECEPTOR; THROMBIN; THROMBIN RECEPTOR; ADHESION RECEPTOR; PROTEASE-ACTIVATED RECEPTOR 4;

ABNORMALITY; BLOOD; CELLS AND CELL COMPONENTS; ENZYME; INJURY; PATHOGENICITY;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FIBRIN FORMATION; FIBRINOLYSIS; FLOW CYTOMETRY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; REGULATORY MECHANISM; THROMBOCYTE ACTIVATION; ANIMAL; ANIMAL MODEL; C57BL MOUSE; CELL MOTION; HUMAN; LEUKOCYTE; MALE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; FIBRINOLYSIS; HUMANS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RECEPTORS, THROMBIN; THROMBIN;

EID: 84937850992     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8835     Document Type: Article

References (70)

1. Siller-Matula, J. M., Schwameis, M., Blann, A., Mannhalter, C. , Jilma, B. Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects. Thromb. Haemost. 106, 1020-1033 (2011).
2. Levi, M. , van der Poll, T. Inflammation and coagulation. Crit. Care Med. 38, S26-S34 (2010).
3. Ma, L. , Dorling, A. The roles of thrombin and protease-activated receptors in inflammation. Semin. Immunopathol. 34, 63-72 (2012).
4. Coughlin, S. R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 3, 1800-1814 (2005).
5. Coughlin, S. R. Thrombin signalling and protease-activated receptors. Nature 407, 258-264 (2000).
6. Sambrano, G. R., Weiss, E. J., Zheng, Y. W., Huang, W. , Coughlin, S. R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413, 74-78 (2001).
7. Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H. , Coughlin, S. R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J. Clin. Invest. 103, 879-887 (1999).
8. Coppinger, J. A. et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096-2104 (2004).
9. Smyth, S. S. et al. Platelet functions beyond hemostasis. J. Thromb. Haemost. 7, 1759-1766 (2009).
10. Coughlin, S. R. , Camerer, E. Participation in inflammation. J. Clin. Invest. 111, 25-27 (2003).
11. Chen, D. et al. Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J. Exp. Med. 205, 1739-1746 (2008).
12. Sugama, Y. et al. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol. 119, 935-944 (1992).
13. Kaplanski, G. et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 92, 1259-1267 (1998).
14. Johnson, K. et al. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J. Immunol. 160, 5130-5135 (1998).
15. Zimmerman, G. A., McIntyre, T. M., Mehra, M. , Prescott, S. M. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J. Cell Biol. 110, 529-540 (1990).
16. Bode, W. Structure and interaction modes of thrombin. Blood. Cells Mol. Dis. 36, 122-130 (2006).
17. Lane, D. A., Philippou, H. , Huntington, J. A. Directing thrombin. Blood 106, 2605-2612 (2005).
18. Rydel, T. J. et al. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 249, 277-280 (1990).
19. Bock, P. E., Panizzi, P. , Verhamme, I. M. Exosites in the substrate specificity of blood coagulation reactions. J. Thromb. Haemost. 5(Suppl 1): 81-94 (2007).
20. Carter, W. J., Cama, E. , Huntington, J. A. Crystal structure of thrombin bound to heparin. J. Biol. Chem. 280, 2745-2749 (2005).
21. Lovely, R. S., Moaddel, M. , Farrell, D. H. Fibrinogen gamma' chain binds thrombin exosite II. J. Thromb. Haemost. 1, 124-131 (2003).
22. Zarpellon, A. et al. Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I. Proc. Natl Acad. Sci. USA 108, 8628-8633 (2011).
23. Celikel, R. et al. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science 301, 218-221 (2003).
24. Dumas, J. J., Kumar, R., Seehra, J., Somers, W. S. , Mosyak, L. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science 301, 222-226 (2003).
25. Sabo, T. M. , Maurer, M. C. Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II. Biochemistry 48, 7110-7122 (2009).
26. Ruggeri, Z. M. et al. Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib. Thromb. Haemost. 104, 894-902 (2010).
27. Gross, P. L., Furie, B. C., Merrill-Skoloff, G., Chou, J. , Furie, B. Leukocyteversus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J. Leukoc. Biol. 78, 1318-1326 (2005).
28. Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C. , Furie, B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med. 8, 1175-1181 (2002).
29. Rumbaut, R. E., Slaff, D. W. , Burns, A. R. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation 12, 259-274 (2005).
30. Ghasemzadeh, M. et al. The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. Blood 121, 4555-4566 (2013).
31. Bombeli, T., Karsan, A., Tait, J. F. , Harlan, J. M. Apoptotic vascular endothelial cells become procoagulant. Blood 89, 2429-2442 (1997).
32. Ravanat, C. et al. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem. J. 282, 7-13 (1992).
33. Vandendries, E. R., Hamilton, J. R., Coughlin, S. R., Furie, B. , Furie, B. C. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc. Natl Acad. Sci. USA 104, 288-292 (2007).
34. Larsen, E. et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59, 305-312 (1989).
35. Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O. , Wagner, D. D. Leukocyte rolling and extravasation are severely compromised in P selectindeficient mice. Cell 74, 541-554 (1993).
36. Greco, N. J., Tandon, N. N. , Jamieson, G. A. Thrombin binding to platelets defines functional receptors: inhibition of thrombin-induced platelet activation by catalytically-inactivated thrombin. Platelets 6, 270-274 (1995).
37. Mosesson, M. W. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb. Haemost. 89, 9-12 (2003).
38. Mosesson, M. W. Update on antithrombin I (fibrin). Thromb. Haemost. 98, 105-108 (2007).
39. Eltzschig, H. K. , Eckle, T. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17, 1391-1401 (2011).
40. von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819-835 (2012).
41. Moake, J. L. Thrombotic microangiopathies. N. Engl. J. Med. 347, 589-600 (2002).
42. Segal, J. B. et al. Coagulation markers predicting cardiac transplant rejection. Transplantation 72, 233-237 (2001).
43. Morrell, C. N., Sun, H., Swaim, A. M. , Baldwin, 3rd W. M. Platelets an inflammatory force in transplantation. Am. J. Transpl. 7, 2447-2454 (2007).
44. Taylor, R. C., Cullen, S. P. , Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9, 231-241 (2008).
45. Jackson, S. P. , Schoenwaelder, S. M. Procoagulant platelets: are they necrotic? Blood 116, 2011-2018 (2010).
46. Nakamura, N., Ban, T., Yamaji, K., Yoneda, Y. , Wada, Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J. Clin. Invest. 101, 1951-1959 (1998).
47. Hoshi, A., Matsumoto, A., Chung, J., Isozumi, Y. , Koyama, T. Activation of coagulation by a thalidomide-based regimen. Blood Coagul. Fibrinolysis 22, 532-540 (2011).
48. Zhou, J. et al. Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells. Thromb. Res. 127, 466-472 (2011).
49. Matsushita, H. et al. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ. Res. 86, 974-981 (2000).
50. Kohli, V., Selzner, M., Madden, J. F., Bentley, R. C. , Clavien, P. A. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 67, 1099-1105 (1999).
51. Scarabelli, T. et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104, 253-256 (2001).
52. Mao, Y., Zhang, M., Tuma, R. F. , Kunapuli, S. P. Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in mice. J. Cereb. Blood Flow Metab. 30, 1044-1052 (2010).
53. Camerer, E. et al. Roles of protease-activated receptors in a mouse model of endotoxemia. Blood 107, 3912-3921 (2006).
54. Guerrero, J. A. et al. In vivo relevance for platelet glycoprotein Ibalpha residue Tyr276 in thrombus formation. J. Thromb. Haemost. 6, 684-691 (2008).
55. Koopman, J., Haverkate, F., Lord, S. T., Grimbergen, J. , Mannucci, P. M. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala-Thr. J. Clin. Invest. 90, 238-244 (1992).
56. Fuentes-Prior, P. et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 404, 518-525 (2000).
57. De Candia, E. et al. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J. Biol. Chem. 276, 4692-4698 (2001).
58. Lindsberg, P. J., Carpen, O., Paetau, A., Karjalainen-Lindsberg, M. L. , Kaste, M. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94, 939-945 (1996).
59. Zhang, R. L., Chopp, M., Chen, H. , Garcia, J. H. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125, 3-10 (1994).
60. Strbian, D., Karjalainen-Lindsberg, M. L., Kovanen, P. T., Tatlisumak, T. , Lindsberg, P. J. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116, 411-418 (2007).
61. Zhao, Y. et al. Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L718-L729 (2011).
62. Roelofs, J. J. et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J. Am. Soc. Nephrol. 17, 131-140 (2006).
63. Leavell, K. J., Peterson, M. W. , Gross, T. J. The role of fibrin degradation products in neutrophil recruitment to the lung. Am. J. Respir. Cell Mol. Biol. 14, 53-60 (1996).
64. Syrovets, T., Lunov, O. , Simmet, T. Plasmin as a proinflammatory cell activator. J. Leukoc. Biol. 92, 509-519 (2012).
65. Zaets, S. B. et al. Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury. Shock 31, 621-626 (2009).
66. Zaets, S. B. et al. Recombinant factor XIII mitigates hemorrhagic shock-induced organ dysfunction. J. Surg. Res. 166, e135-e142 (2011).
67. Ware, J., Russell, S. R., Marchese, P. , Ruggeri, Z. M. Expression of human platelet glycoprotein Ib alpha in transgenic mice. J. Biol. Chem. 268, 8376-8382 (1993).
68. Ware, J., Russell, S. , Ruggeri, Z. M. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc. Natl Acad. Sci. USA 97, 2803-2808 (2000).
69. Minaschek, G., Bereiter-Hahn, J. , Bertholdt, G. Quantitation of the volume of liquid injected into cells by means of pressure. Exp. Cell Res. 183, 434-442 (1989).
70. Lijnen, H. R., van Hoef, B., Beelen, V. , Collen, D. Characterization of the murine plasma fibrinolytic system. Eur. J. Biochem. 224, 863-871 (1994).